Herbert Yu, MD, PhD
Herbert Yu, MD, PhD
- Professor and Director, Cancer Epidemiology Program
- Associate Director for Cancer Control and Population Sciences
- MD, Shanghai Medical University, Shanghai, China
- PhD, Clinical Biochemistry University of Toronto, Toronto, Canada
- MSc, Epidemiology University of Toronto, Toronto, Canada
Dr. Yu has recently joined the University of Hawaii Cancer Center as the director of the Cancer Epidemiology Program and associate director for Cancer Control and Population Sciences. Previously, he spent 10 years as a teacher, researcher and mentor in the Schools of Public Health and Medicine at Yale University where he had achieved the status of full professor.
Dr. Yu received training in epidemiology and laboratory research and has extensive experience in population-based epidemiologic investigation and patient-oriented clinical studies. His most recent research focuses on gene-environment interaction in cancer development, molecular features of tumor progression, and changes in epigenetic regulation in relation to tumor progression and cancer prognosis.
He has completed many clinical and epidemiologic studies on several major cancer sites, including the breast, ovary, liver, lung, endometrium, and prostate. These studies span a wide range of topics, including genetic susceptibility, genotypes and phenotypes of sex steroid hormone and growth factors and their interactions, lifestyle influence on epigenetic regulation, and biomarkers for cancer prognosis and patient management.
Dr. Yu has investigated DNA methylation in tumor suppressor and DNA repair genes, methylator phenotype in relation to tumor progression, methylation pattern in multiple promoters, methylation regulation of microRNA, and physical activity and epigenetic regulation. In addition, he has been involved in several GWAS projects, and is the principal investigator of a population-based case-control study of hepatocellular carcinoma and co-investigator of several clinical and epidemiological studies funded by the National Institutes of Health.
- Lu L, Risch H, Irwin M, Mayne S., Cartmel B., Schwartz P, Rutherford T, Yu H. Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer 2011 (in press)
- Zeng H, Irwin ML, Lu L, Risch H, Mayne S, Mu L, Deng Q, Scarampi L, Mitidieri M, Katsaros D, Yu H. Physical activity and breast cancer survival â an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1. Breast Cancer Res Treat 2011 (in press).
- Arem H, Irwin, ML, Zhou Y, Lu L, Risch H, Yu H. Physical activity and endometrial cancer in a population-based case-control study. Cancer Causes Control 2011; 22(2):219-226.
- Lu L, Zhang C, Zhu G, Irwin M, Risch H, Menato G, Mitidieri M, Katsaros D, Yu H. Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res 2011; 13:R56.
Publication list via PubMed
- R01 CA138698
âEpidemiologic Study of Hepatocellular Carcinoma in the USâ
August 1, 2010-June 31, 2015
- H. Yu, Subcontract Principal Investigator, (G. Ho, Principal Investigator)
âSerum levels of EGFR-signaling-network activators/inhibitors and risk of lung cancerâ
July 1, 2010-June 30, 2013
- H. Yu, Co-Investigator, (E. Claus, Principal Investigator)
âThe Meningioma Consortium: Genome-Wide Association Studyâ
July 1, 2010-June 30, 2015
- H. Yu, Co-Investigator, (M. Irwin, Principal Investigator)
âRCT of exercise on aromatase inhibitor side effects in breast cancer survivorsâ
July 1, 2009-June 30, 2013